Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Lymphoma and NRAS[original query] |
---|
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Sep 25 (9): 1203-11. Aggarwal Nidhi, Swerdlow Steven H, Kelly Lindsey M, Ogilvie Jennifer B, Nikiforova Mariana N, Sathanoori Malini, Nikiforov Yuri |
Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas. Pigment cell & melanoma research 2013 Sep 26 (5): 646-53. Niu Hai-Tao, Zhou Qi-Ming, Wang Fang, Shao Qiong, Guan Yuan-Xiang, Wen Xi-Zhi, Chen Li-Zhen, Feng Qi-Sheng, Li Wei, Zeng Yi-Xin, Zhang Xiao-S |
Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%. Genes, chromosomes & cancer 2014 Jun 53 (6): 524-36. Mühlbacher Verena, Zenger Melanie, Schnittger Susanne, Weissmann Sandra, Kunze Franziska, Kohlmann Alexander, Bellos Frauke, Kern Wolfgang, Haferlach Torsten, Haferlach Claud |
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 2015 Feb 121 (3): 448-56. Villaruz Liza C, Socinski Mark A, Abberbock Shira, Berry Lynne D, Johnson Bruce E, Kwiatkowski David J, Iafrate A John, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross, Sequist Lecia V, Haura Eric B, Ladanyi Mark, Kurland Brenda F, Kugler Kelly, Minna John D, Bunn Paul A, Kris Mark |
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer 2015 Dec . Steuer Conor E, Behera Madhusmita, Berry Lynne, Kim Sungjin, Rossi Michael, Sica Gabriel, Owonikoko Taofeek K, Johnson Bruce E, Kris Mark G, Bunn Paul A, Khuri Fadlo R, Garon Edward B, Ramalingam Suresh |
Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Sep . Li Shiyong, Choi Yoon-La, Gong Zhuolin, Liu Xiao, Lira Maruja, Kan Zhengyan, Oh Ensel, Wang Jian, Ting Jason C, Ye Xiangsheng, Reinhart Christoph, Liu Xiaoqiao, Pei Yunfei, Zhou Wei, Chen Ronghua, Fu Shijun, Jin Gang, Jiang Awei, Fernandez Julio, Hardwick James, Kang Min Woong, I Hoseok, Zheng Hancheng, Kim Jhingook, Mao M |
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma. Hematological oncology 2016 Jun . Saillard Colombe, Guermouche Helene, Derrieux Coralie, Bruneau Julie, Frenzel Laurent, Couronne Lucile, Asnafi Vahid, Macintyre Elizabeth, Trinquand Amélie, Lhermitte Ludovic, Molina Thierry, Suarez Felipe, Lemonnier Francois, Kosmider Olivier, Delarue Richard, Hermine Olivier, Cheminant Morga |
MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2018 31 (2): 130-136. Novosad Olga, Skrypets Tanya, Pastushenko Yan, Titorenko Iryna, Martynchyk Arina, Skachkova Oksana, Inomistova Mariia, Gorbach Alex, Khranovska Nataliia, Kryachok Iri |
Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma. JAMA dermatology 2018 12 155 (5): 604-609. Wong Kim, Robles-Espinoza Carla Daniela, Rodriguez David, Rudat Saskia S, Puig Susana, Potrony Miriam, Wong Chi C, Hewinson James, Aguilera Paula, Puig-Butille Joan Anton, Bressac-de Paillerets Brigitte, Zattara Hélène, van der Weyden Louise, Fletcher Christopher D M, Brenn Thomas, Arends Mark J, Quesada Víctor, Newton-Bishop Julia A, Lopez-Otin Carlos, Bishop D Timothy, Harms Paul W, Johnson Timothy M, Durham Alison B, Lombard David B, Adams David |
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas. Oncology letters 2018 Dec 16 (6): 7091-7096. Osella-Abate Simona, Mereu Elisabetta, Pellegrino Elisa, Bergaggio Elisa, Ribero Simone, Bertero Luca, Lisa Francesco, Fierro Maria Teresa, Giulio Papotti Mauro, Piva Rober |
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 9 34 (2): 336-347. Egan Caoimhe, Lack Justin, Skarshaug Shannon, Pham Thu Anh, Abdullaev Zied, Xi Liqiang, Pack Svetlana, Pittaluga Stefania, Jaffe Elaine S, Raffeld Ma |
Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. Blood cancer discovery 2020 11 1 (1): 112-125. Liu Zhaoqi, Filip Ioan, Gomez Karen, Engelbrecht Dewaldt, Meer Shabnum, Lalloo Pooja N, Patel Pareen, Perner Yvonne, Zhao Junfei, Wang Jiguang, Pasqualucci Laura, Rabadan Raul, Willem Pasca |
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. Cancer reports (Hoboken, N.J.) 2021 9 5 (7): e1545. Yoshida Masanori, Tomizawa Daisuke, Yoshimura Satoshi, Osumi Tomoo, Nakabayashi Kazuhiko, Ogata-Kawata Hiroko, Ishiwata Keisuke, Sato-Otsubo Aiko, Kimura Yui, Ito Shuichi, Matsumoto Kimikazu, Deguchi Takao, Kiyokawa Nobutaka, Yoshioka Takako, Hata Kenichiro, Kato Motohi |
Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG). British journal of haematology 2021 7 194 (4): 718-729. Ohki Kentaro, Kiyokawa Nobutaka, Watanabe Satoru, Iwafuchi Hideto, Nakazawa Astuko, Ishiwata Keisuke, Ogata-Kawata Hiroko, Nakabayashi Kazuhiko, Okamura Kohji, Tanaka Fumiko, Fukano Reiji, Hata Kenichiro, Mori Tetsuya, Moriya Saito Akiko, Hayashi Yasuhide, Taga Takashi, Sekimizu Masahiro, Kobayashi Ryoji, |
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations. Cancer research and treatment 2021 5 54 (1): 30-39. Choi Yoon Ji, Choi Jung Yoon, Kim Ju Won, Lim Ah Reum, Lee Youngwoo, Chang Won Jin, Lee Soohyeon, Sung Jae Sook, Chung Hee-Joon, Lee Jong Won, Kang Eun Joo, Kim Jung Sun, Lim Taekyu, Kim Hye Sook, Kim Yu Jung, Ahn Mi Sun, Kim Young Saing, Park Ji Hyun, Lim Seungtaek, Cho Sung Shim, Cho Jang Ho, Shin Sang Won, Park Kyong Hwa, Kim Yeul Ho |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood advances 2021 10 6 (2): 637-651. Witte Hanno M, Künstner Axel, Hertel Nadine, Bernd Heinz-Wolfram, Bernard Veronica, Stölting Stephanie, Merz Hartmut, von Bubnoff Nikolas, Busch Hauke, Feller Alfred C, Gebauer Nikl |
Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing. Molecular carcinogenesis 2022 10 62 (2): 200-209. Hou Yue, Zi Jie, Liu Shuo, Ge Qinyu, Ge Zhe |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: